Company news
Hemostemix Inc news in 2025
Hemostemix Inc's news releases, calls and decks from 2025, newest first.
Hemostemix Presents at TERMIS 2025, Freiburg, Germany
May 20, 2025
Hemostemix Closes Private Placement of USD $336,500 at $0.295 per Share
May 12, 2025
Hemostemix at Invest Stuttgart
May 8, 2025
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
April 23, 2025
Hemostemix's Pitch to Wall Street: ACP-01 Vascular Dementia Trial will Generate $5,365,000, Capture Data, as a Phase 1 Clinical Trial
March 17, 2025
Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
March 14, 2025
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
March 6, 2025
Hemostemix Sells Its 23rd ACP-01 Therapy Convertible Debenture
March 5, 2025
RETRANSMISSION: Hemostemix Licenses CytoImmune's BioReactor Technologies
February 20, 2025
Hemostemix Licenses CytoImmune's BioReactor Technologies
February 19, 2025
Hemostemix Provides Corporate Update
February 13, 2025
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
February 11, 2025
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
February 10, 2025
CytoImmune Subscribes for 1,634,466 Hemostemix Common Shares
February 4, 2025
Hemostemix Expands to the Dominican Republic
February 3, 2025
Hemostemix Announces First Sales Orders for ACP-01
January 29, 2025
Hemostemix Up-lists to TradeGateExchange in Germany
January 27, 2025
Hemostemix Up-Lists to OTCQB While it Presents its Global Scale-Up Strategy at Two Investor Conferences in Puerto Rico
January 23, 2025
Hemostemix Announces Grant of Stock Options
January 22, 2025
Hemostemix Presents at Puerto Rico Investor Summits: Showcasing Global Scale-Up Strategy and Economic Impact
January 20, 2025
Hemostemix Settlement via Depository Trust Company Plus OTCQB Update
January 13, 2025
Hemostemix and CytoImmune Amend Manufacturing Agreement to Accelerate Global Scale-Up
January 9, 2025
Hemostemix Announces the Incorporation of Hemostemix PR Inc: 50% Reimbursement of R&D Expenses in Cash
January 6, 2025
Hemostemix is Up-Listing in the USA to Generate Liquidity
January 2, 2025
Decks in 2025
- Investor Presentation (2025)
Investor deck · 22 slides · Nov 3, 2025